Biocartis
Tracked across 1 events · 6 articles · First seen Sep 16, 2026 · Last active Sep 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Researchers led by City of Hope developed an investigational liquid biopsy called PANXEON that could detect pancreatic cancer at its earliest, potentially curable stages. The large international study, published in Nature Medicine, tested the blood…
Impact: Biocartis holds an option to acquire the rights to PANXEON, and Ajay Goel is a paid consultant to the company, giving it potential commercial upside if the test advances.
Sep 16, 2026 · 6 articles
60
Biocartis holds optionCity of Hope PANXEON...
ERGEN INTELLIGENCE
Track Biocartis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard